Nicholas Everage serves as the Senior Director and Head of Epidemiology at Biogen, where he plays a pivotal role in shaping the scientific and operational strategies that underpin the company's commitment to advancing healthcare through data-driven insights. With over 20 years of experience in the...
Nicholas Everage serves as the Senior Director and Head of Epidemiology at Biogen, where he plays a pivotal role in shaping the scientific and operational strategies that underpin the company's commitment to advancing healthcare through data-driven insights. With over 20 years of experience in the pharmaceutical and biotechnology sectors, Nicholas leads a dynamic team of 13 professionals dedicated to addressing epidemiological and real-world evidence needs across the entire product lifecycle—from early research phases to post-marketing evaluations. His expertise in biostatistics and public health, combined with a deep understanding of the regulatory landscape, enables him to effectively guide the integration of epidemiological data into clinical decision-making processes.
Nicholas is a strategic visionary and a key influencer within Biogen's Quantitative Sciences Leadership Team, collaborating closely with heads of Clinical, Medical Biostatistics, and Real-World Data Analytics. His leadership is characterized by a commitment to operational excellence and a passion for leveraging meaningful data science to alleviate human suffering. Under his guidance, the epidemiology team not only conducts rigorous analyses but also develops innovative methodologies that enhance the understanding of disease patterns and treatment outcomes.
His involvement in key projects includes the establishment of robust registries and the utilization of Electronic Data Capture (EDC) systems to streamline data collection and analysis. By fostering partnerships with Contract Research Organizations (CROs) and utilizing advanced data analytics, Nicholas ensures that Biogen remains at the forefront of evidence generation in the life sciences industry. His award-winning contributions have solidified his reputation as a thought leader, driving impactful change and improving patient outcomes through the strategic application of epidemiological research.
